Achieving Real Time Multi-Enterprise Collaboration and Compliance in Complex Life Sciences Networks
Learn how to achieve real-time visibility, compliance, and collaboration across life sciences supply chains - join us to explore strategies for traceability, risk management, and seamless CMO onboarding.
Join us for an insightful discussion around visibility and collaboration across external life sciences manufacturing.
In this webinar, learn how to:
Achieve real-time traceability, visibility, and risk management across multi-tier supply chains down to the batch level.
Ensure chain of custody for high-value products and compliance with global regulatory requirements.
Connect the supply chain from raw materials to the patient.
Utilize standardization and maturity models to enable rapid onboarding of contract manufacturing organizations (CMOs) and suppliers.
Speakers
Shirell James SVP One Network Enterprises (A Blue Yonder Company)
Shirell James has more than 20 years' experience as a leader in supply chain technology. She is responsible for the strategy of the EMEA region of One Network Enterprises and has built a growing and successful team, consulting at senior levels of large organizations with extensive experience in pharmaceuticals, healthcare, retail, consumer goods, logistics, and automotive. She has a particular interest in the Pharmaceutical industry and how Digital Supply Chain Networks can enable pharmaceutical companies and their CDMOs (Contract Development and Manufacturing Organisations) to get next generation pharmaceuticals to patients at scale and lower cost. Her technology focus is how Digital Supply Chain Networks can enable complex multi-party supply chains to be more resilient, reliable and agile, and she has provided thought leadership globally on how digital supply chain technologies can be utilized to drive value for Fortune 500 companies.
Paolo Guidici CMC and Supply Chain Professional The Janssen Pharmaceutical Companies of Johnson & Johnson
Paolo is a seasoned pharmaceutical development and manufacturing professional with over 15 years of experience at both innovator and contract manufacturing organizations (CMOs). He is an expert in the technical development of injectable drug products, including liquid and lyophilized parenterals, extending to commercial drug products. He possesses competence in late-stage large molecule and fill-finish operations, with hands-on experience in process transfer. Paolo has extensive knowledge in early and late-phase solid dose formulation development and is an accomplished leader of multidisciplinary chemistry, manufacturing, and control (CMC) teams, overseeing both development and commercial project responsibilities. With direct experience in manufacturing areas and a profound understanding of good manufacturing practices (GMP).